en

PRODUCT DETAIL

Bydureon 2 mg injekčná suspenzia s predĺženým uvoľňovaním v naplnenom pere

Code 2205D
MA number EU/1/11/696/006
Product Form: sus ijp 12 (3x4)x0,85 ml/2 mg (pero napl.jednod. BCise)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BJ Glucagon-like peptide-1 receptor (GLP-1) analogues
A10BJ01 Exenatide
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - known active substance
MA issued: 17.06.2011
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 10.03.2021
eu-flag.png sk-flag.png